| Dr Mario Estrin Trabulsy, MD | |
|
111 Colchester Ave, Fahc Emergency Department, Burlington, VT 05401-1473 | |
| (802) 847-3982 | |
| Not Available |
| Full Name | Dr Mario Estrin Trabulsy |
|---|---|
| Gender | Female |
| Speciality | Emergency Medicine |
| Location | 111 Colchester Ave, Burlington, Vermont |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407889769 | NPI | - | NPPES |
| 0VN1360 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 42-0009271 (Vermont) | Primary |
| Entity Name | University Of Vermont Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1659309615 PECOS PAC ID: 3779491071 Enrollment ID: O20040406001047 |
News Archive
A strategy developed by Massachusetts General Hospital (MGH) researchers to shield the ovaries of female mammals from the damaging effects of radiation and chemotherapy has passed an important milestone. A collaborative study with investigators from Oregon Health and Sciences University (OHSU), published online in the journal Fertility and Sterility, reports that brief preexposure of the ovaries to an FDA-approved agent called FTY720 preserved the fertility of female rhesus monkeys exposed to potentially lethal doses of radiation.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at $14.35 per share. The total proceeds, before expenses, to Momenta will be approximately $57.4 million. The offering is expected to close on December 13, 2010, subject to customary closing conditions.
An evolutionary analysis of public health data during a major disease outbreak, such as bird flu, E. coli contamination of food or the current Ebola outbreak could help the emergency services plan their response and contain the disease more effectively.
International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mario Estrin Trabulsy, MD 1086 Braeloch Rd, Colchester, VT 05446-7478 Ph: (802) 893-7624 | Dr Mario Estrin Trabulsy, MD 111 Colchester Ave, Fahc Emergency Department, Burlington, VT 05401-1473 Ph: (802) 847-3982 |
News Archive
A strategy developed by Massachusetts General Hospital (MGH) researchers to shield the ovaries of female mammals from the damaging effects of radiation and chemotherapy has passed an important milestone. A collaborative study with investigators from Oregon Health and Sciences University (OHSU), published online in the journal Fertility and Sterility, reports that brief preexposure of the ovaries to an FDA-approved agent called FTY720 preserved the fertility of female rhesus monkeys exposed to potentially lethal doses of radiation.
Momenta Pharmaceuticals, Inc., a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the pricing of an underwritten public offering of 4,000,000 shares of its common stock at $14.35 per share. The total proceeds, before expenses, to Momenta will be approximately $57.4 million. The offering is expected to close on December 13, 2010, subject to customary closing conditions.
An evolutionary analysis of public health data during a major disease outbreak, such as bird flu, E. coli contamination of food or the current Ebola outbreak could help the emergency services plan their response and contain the disease more effectively.
International research led by Monash University and the Peter Doherty Institute for Infection and Immunity has achieved a proof of concept for a new, fast, portable saliva screening test that uses an infrared light technology to confirm infection with SARS-CoV-2.
› Verified 8 days ago
William Alexander Manning, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Dr. Richard Page Hudson Iii, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fahc Emergency Department, Burlington, VT 05401 Phone: 802-847-3982 Fax: 802-847-5963 | |
Dr. Daniel John Ackil, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-2434 | |
John I Ellis, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Mchv Campus - Ed, Burlington, VT 05401 Phone: 802-847-3982 | |
David H Murman, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-875-1237 | |
Elizabeth N Malik, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Burlington, VT 05401 Phone: 802-847-0000 | |
Dr. David Ward Clauss, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 111 Colchester Ave, Fahc Emergency Department, Burlington, VT 05401 Phone: 802-847-3982 Fax: 802-847-5963 |